COM:ELITEPHARMA
Elite Pharmaceuticals
- Stock
Last Close
0.52
07/11 20:59
Market Cap
189.08M
Beta: -
Volume Today
459.25K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Mar '14 | Mar '15 | Mar '16 | Mar '17 | Mar '18 | Mar '19 | Mar '20 | Mar '21 | Mar '22 | Mar '23 | Mar '24 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 1.65M - | 2.48M 50.87% | 3.16M 27.42% | 4.85M 53.50% | 5.66M 16.52% | 4.71M 16.80% | 4.33M 8.03% | 4.58M 5.74% | 5.88M 28.38% | 8.15M 38.61% | 6.47B 79,326.13% | |
average payables | 1.77M - | 1.11M 37.43% | 902.21K 18.53% | 1.43M 58.18% | 1.35M 5.13% | 1.52M 12.02% | 1.48M 2.65% | 1.25M 15.09% | 1.18M 5.86% | 1.94M 64.27% | 1.36B 69,959.22% | |
average receivables | 698.62K - | 1.09M 55.92% | 1.49M 36.64% | 1.23M 17.21% | 804.97K 34.67% | 998.84K 24.08% | 2.71M 171.75% | 3.80M 40.06% | 3.28M 13.80% | 3.08M 6.13% | 9.73B 316,137.56% | |
book value per share | -0.18 - | -0.06 66.50% | 0.02 128.20% | 0.03 84.73% | 0.02 24.16% | 0.01 39.69% | 0.01 8.54% | 0.02 33.79% | 0.02 45.71% | 0.03 14.56% | 56.71 198,238.12% | |
capex per share | -0.00 - | -0.00 179.04% | -0.00 14.38% | -0.00 54.44% | -0.00 73.79% | -0.00 93.19% | -0.00 78.73% | -0.00 733.27% | -0.00 40.98% | -0.01 1,048.01% | -0.80 13,978.58% | |
capex to depreciation | -1.24 - | -3.43 177.85% | -2.92 14.80% | -1.55 47.12% | -0.28 82.16% | -0.02 94.48% | -0.02 52.03% | -0.22 835.41% | -0.35 60.55% | -4.27 1,127.66% | -0.55 87.10% | |
capex to operating cash flow | 0.13 - | 0.13 0.52% | 0.70 433.01% | 0.14 80.11% | 0.06 59.22% | 0.00 95.07% | 0.02 591.89% | -0.10 630.23% | -0.08 25.86% | -1.72 2,142.97% | 0.25 114.36% | |
capex to revenue | -0.12 - | -0.40 226.90% | -0.16 60.84% | -0.11 26.48% | -0.04 67.86% | -0.00 93.14% | -0.00 23.15% | -0.01 569.33% | -0.02 18.86% | -0.00 98.91% | -0.01 8,413.14% | |
cash per share | 0.01 - | 0.01 15.79% | 0.02 35.31% | 0.01 26.05% | 0.01 28.61% | 0.00 68.98% | 0.00 51.40% | 0.00 149.01% | 0.01 149.45% | 0.01 8.45% | 7.00 90,404.58% | |
days of inventory on hand | 217.96 - | 367.23 68.48% | 268.10 26.99% | 397.03 48.09% | 509.17 28.25% | 350.62 31.14% | 150.96 56.94% | 135.40 10.31% | 140.87 4.04% | 0.20 99.86% | 155.93 78,449.90% | |
days payables outstanding | 249.82 - | 146.88 - | 64.96 55.77% | 172.37 165.34% | 106.79 38.05% | 57.50 46.15% | 25.11 56.33% | 29.90 19.08% | 0.05 99.83% | 32.73 64,261.48% | ||
days sales outstanding | 58.07 - | 105.27 81.28% | 44.69 57.55% | 35.37 20.85% | 33.07 6.50% | 63.75 92.73% | 83.30 30.68% | 50.28 39.64% | 34.60 31.20% | 0.03 99.90% | 125.39 379,077.44% | |
debt to assets | 0.17 - | 0.12 27.11% | 0.11 5.05% | 0.08 32.53% | 0.13 67.20% | 0.16 26.39% | 0.16 1.05% | 0.09 43.73% | 0.08 12.86% | 0.10 20.11% | 0.10 4.91% | |
debt to equity | -0.05 - | -0.09 81.63% | 0.33 463.29% | 0.10 68.41% | 0.22 109.04% | 0.35 61.90% | 0.38 8.23% | 0.15 61.04% | 0.11 25.11% | 0.13 21.71% | 0.14 7.93% | |
dividend yield | ||||||||||||
earnings yield | -0.51 - | 0.20 138.47% | -0.00 101.67% | 0.03 1,026.64% | -0.05 252.30% | -0.11 147.01% | -0.04 66.26% | 0.09 333.88% | 0.25 180.13% | 150.13 59,491.58% | 129.43 13.79% | |
enterprise value | 186.92M - | 143.46M 23.25% | 201.05M 40.14% | 117.85M 41.38% | 76.41M 35.16% | 83.12M 8.78% | 61.16M 26.42% | 55.77M 8.82% | 29.57M 46.98% | 25.43M 13.99% | 1.39B 5,371.43% | |
enterprise value over ebitda | -39.24 - | -9.03 76.99% | -784.31 8,587.08% | -17.78 97.73% | -9.51 46.53% | -10.55 10.94% | -80.17 660.10% | 15.36 119.16% | 4.54 70.42% | 0.01 99.83% | 0.03 343.78% | |
ev to operating cash flow | -44.33 - | -9.50 78.57% | -72.70 665.36% | -14.95 79.44% | -15.89 6.29% | -12.24 22.99% | -34.09 178.63% | 17.46 151.21% | 4.54 73.98% | 7.62 67.66% | -0.42 105.57% | |
ev to sales | 40.62 - | 28.61 29.58% | 16.09 43.77% | 12.23 23.98% | 10.24 16.22% | 10.98 7.20% | 3.40 69.05% | 2.20 35.35% | 0.92 58.29% | 0.00 99.92% | 0.02 3,200.26% | |
free cash flow per share | -0.01 - | -0.03 180.33% | -0.01 75.81% | -0.01 53.21% | -0.01 40.41% | -0.01 31.01% | -0.00 73.74% | 0.00 238.22% | 0.01 95.81% | -0.00 139.81% | -4.03 170,089.99% | |
free cash flow yield | -0.03 - | -0.12 359.74% | -0.02 80.50% | -0.07 216.64% | -0.06 10.62% | -0.08 31.01% | -0.03 62.48% | 0.05 261.26% | 0.17 236.15% | -0.08 147.98% | -26.33 32,158.23% | |
graham net net | -0.21 - | -0.09 59.18% | -0.01 88.89% | 0.01 173.43% | -0.00 140.87% | -0.01 221.87% | -0.01 4.86% | -0.00 81.11% | 0.00 332.32% | 0.00 30.11% | 2.06 69,586.15% | |
graham number | 0.91 - | 0.25 71.97% | 0.02 92.36% | 0.06 187.80% | 0.05 12.25% | 0.06 22.05% | 0.03 53.52% | 0.05 63.77% | 0.07 54.19% | 1.67 2,280.04% | 158.95 9,398.12% | |
income quality | 0.04 - | -0.52 1,295.64% | 4.05 875.54% | -2.07 151.09% | 1.31 163.29% | 0.73 44.09% | 0.80 9.38% | 0.63 21.61% | 0.73 16.53% | 0.94 28.16% | -0.16 117.41% | |
intangibles to total assets | 0.26 - | 0.25 5.71% | 0.20 18.31% | 0.19 6.98% | 0.25 33.50% | 0.27 8.85% | 0.27 2.22% | 0.25 4.71% | 0.19 25.49% | 0.16 17.85% | 0.08 51.11% | |
interest coverage | -5.87 - | -57.47 878.83% | -29.63 48.44% | -30.88 4.21% | -26.98 12.63% | -24.81 8.04% | -6.42 74.11% | 8.11 226.24% | 26.44 226.09% | -1.82 106.88% | -18.33 907.09% | |
interest debt per share | 0.01 - | 0.01 45.71% | 0.01 1.04% | 0.00 40.94% | 0.01 57.70% | 0.01 1.58% | 0.01 1.41% | 0.00 46.89% | 0.00 5.17% | -1.09 37,306.70% | 7.64 797.53% | |
inventory turnover | 1.67 - | 0.99 40.65% | 1.36 36.97% | 0.92 32.47% | 0.72 22.03% | 1.04 45.22% | 2.42 132.26% | 2.70 11.49% | 2.59 3.88% | 1.84K 70,864.06% | 2.34 99.87% | |
invested capital | -0.05 - | -0.09 81.63% | 0.33 463.29% | 0.10 68.41% | 0.22 109.04% | 0.35 61.90% | 0.38 8.23% | 0.15 61.04% | 0.11 25.11% | 0.13 21.71% | 0.14 7.93% | |
market cap | 189.84M - | 147.80M 22.14% | 208.91M 41.34% | 125.80M 39.78% | 79.61M 36.72% | 81.42M 2.27% | 58.26M 28.44% | 56.58M 2.89% | 35.32M 37.57% | 29.37M 16.84% | 155.36M 428.91% | |
net current asset value | -95.59M - | -48.32M 49.45% | -4.00M 91.72% | 9.77M 344.07% | 1.30M 86.74% | -4.15M 420.33% | -4.05M 2.41% | 2.16M 153.27% | 8.93M 314.19% | 9.57M 7.16% | 13.94B 145,530.73% | |
net debt to ebitda | 0.61 - | 0.27 55.46% | 30.68 11,131.53% | 1.20 96.09% | 0.40 66.85% | -0.22 154.38% | -3.80 1,657.13% | -0.22 94.09% | -0.88 294.25% | -0.00 99.86% | 0.03 2,641.19% | |
net income per share | -0.21 - | 0.05 123.46% | -0.00 102.07% | 0.00 548.37% | -0.00 201.54% | -0.01 147.01% | -0.00 76.38% | 0.01 300.47% | 0.01 63.17% | 4.35 49,346.52% | 19.80 354.85% | |
operating cash flow per share | -0.01 - | -0.03 180.50% | -0.00 83.94% | -0.01 129.08% | -0.01 35.74% | -0.01 38.10% | -0.00 74.17% | 0.00 257.15% | 0.01 90.14% | 0.00 48.82% | -3.23 98,143.29% | |
payables turnover | 1.46 - | 2.49 - | 5.62 126.09% | 2.12 62.31% | 3.42 61.42% | 6.35 85.71% | 14.54 128.99% | 12.21 16.03% | 7.18K 58,699.54% | 11.15 99.84% | ||
receivables turnover | 6.29 - | 3.47 44.84% | 8.17 135.55% | 10.32 26.33% | 11.04 6.95% | 5.73 48.11% | 4.38 23.48% | 7.26 65.67% | 10.55 45.34% | 11.04K 104,514.20% | 2.91 99.97% | |
research and ddevelopement to revenue | 0.86 - | 2.94 241.27% | 0.99 66.14% | 0.86 13.38% | 1.29 49.75% | 1.00 22.16% | 0.31 69.38% | 0.20 34.48% | 0.13 37.66% | 0.18 44.56% | 0.12 33.04% | |
return on tangible assets | -5.37 - | 1.48 127.55% | -0.03 101.81% | 0.14 609.48% | -0.16 216.02% | -0.52 229.43% | -0.12 76.59% | 0.26 312.81% | 0.31 19.93% | 127.62 40,796.64% | 0.26 99.80% | |
revenue per share | 0.01 - | 0.01 14.64% | 0.02 118.63% | 0.01 38.04% | 0.01 18.47% | 0.01 0.78% | 0.02 132.57% | 0.03 24.49% | 0.03 18.61% | 33.72 105,526.78% | 55.76 65.37% | |
roe | 1.19 - | -0.83 170.03% | -0.06 92.65% | 0.15 342.72% | -0.20 233.88% | -0.81 309.56% | -0.21 74.18% | 0.32 249.84% | 0.35 11.99% | 152.27 43,062.05% | 0.35 99.77% | |
roic | 0.07 - | 0.52 665.24% | -0.32 161.02% | -0.48 49.87% | -0.34 28.33% | -0.57 66.53% | -0.15 73.35% | 0.14 190.69% | 0.22 61.66% | 68.18 30,516.91% | -6.78 109.94% | |
sales general and administrative to revenue | 0.48 - | 0.63 32.64% | 0.26 58.95% | 0.25 2.19% | 0.35 36.41% | 0.43 23.13% | 0.19 55.43% | 0.13 30.67% | 0.14 5.60% | 0.15 8.04% | 0.13 15.86% | |
shareholders equity per share | -0.18 - | -0.06 66.50% | 0.02 128.20% | 0.03 84.73% | 0.02 24.16% | 0.01 39.69% | 0.01 8.54% | 0.02 33.79% | 0.02 45.71% | 0.03 14.56% | 56.71 198,238.12% | |
stock based compensation to revenue | 0.02 - | 0.05 187.64% | 0.07 39.96% | 0.08 9.76% | 0.16 96.88% | 0.23 44.71% | 0.06 74.81% | 0.04 35.52% | 0.02 34.29% | 0.00 99.93% | 0.15 869,699.30% | |
tangible asset value | -87.55M - | -41.11M 53.04% | 4.75M 111.56% | 19.24M 305.01% | 10.76M 44.08% | 4.76M 55.75% | 4.02M 15.55% | 9.52M 136.66% | 18.59M 95.30% | 22.62M 21.69% | 51.24B 226,441.92% | |
tangible book value per share | -0.19 - | -0.07 63.22% | 0.01 110.14% | 0.02 225.45% | 0.01 41.08% | 0.01 56.74% | 0.00 17.39% | 0.01 108.88% | 0.02 82.23% | 0.02 21.41% | 50.46 225,877.04% | |
working capital | 3.76M - | 7.26M 92.93% | 12.06M 66.07% | 15.07M 24.95% | 8.59M 43.01% | 1.95M 77.29% | 1.61M 17.36% | 6.38M 295.98% | 12.17M 90.64% | 13.68M 12.41% | 26.96B 197,056.51% |
All numbers in (except ratios and percentages)